General Archive
-
News releases
MRC Technology forms alliance with world leading translational research centres to accelerate global drug development
Six of the world’s top translational health research centres have come together to form a new Global Alliance of Leading…
-
News releases
MRC Technology and Chinese Academy of Science collaborate to identify new targets for drug discovery
The collaboration will combine the SIBCB’s research expertise in generating potential new drug targets, with MRC Technology’s experience in further…
-
News releases
MRC Technology supports Parkinson’s UK through its research grant terms approval service
Parkinson’s UK is the latest medical research funder to benefit from its recently launched research grant terms approval service. As…
-
Articles
Justin Bryans in Nature Reviews Drug Discovery
Justin Bryans, MRC Technology’s Director of Drug Discovery, has been quoted in a Nature Reviews Drug Discovery article about funding…
-
News releases
MRC Technology launches small molecule compound library access scheme
Scheme provides access to a representative subset of 9,000 compounds from 150,000 strong small molecule compound library to academic research…
-
News releases
Intellect Neurosciences and MRC Technology announce humanization of next-generation monoclonal antibody to amyloid beta with reduced potential for inflammation in the brain of Alzheimer’s patients
MRC Technology and Intellect Neurosciences have completed humanization of 82E1, a mouse monoclonal antibody to create a high-affinity stabilized IgG4…
-
News releases
New postpartum haemorrhage drug discovery project launched
A collaboration between MRC Technology and Dr Andrew Blanks at the University of Warwick has been launched to develop inhibitors…
-
News releases
GPCR collaboration with Heptares extended
The collaboration covers the structure and active conformations of G-protein coupled receptors (GPCRs), and other transmembrane proteins. Building upon their…
-
News releases
New ACTH-dependent Cushing’s Syndrome drug discovery project launched
Collaboration between MRC Technology and Queen Mary University of London to develop melanocortin receptor type 2 (MC2R) antagonists for the…
-
News releases
New drug discovery collaborations with Queen Mary University of London launched
The first collaboration will develop selective formyl peptide receptor 2 (FPR2) agonists for the treatment of ischaemia reperfusion injury. The…
-
News releases
MRCT announce second drug discovery collaboration with University of Bristol
This project will focus on developing novel modulators of the second galanin receptor subtype (GalR2) for neuropathic pain, a major…
-
News releases
Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
The collaboration will focus on the development of monoclonal antibodies that can be commercialized as drugs to control infection and…